The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

Annual COVID-19 shots for healthy young adults and children will no longer be necessary under new guidelines suggested by the ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Shares of Moderna surged to lead S&P 500 gainers in early afternoon trading Tuesday, hours after the Food and Drug ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The United States will restrict routine Covid-19 boosters to people over 65 or those at higher risk of serious illness, while ...